...
首页> 外文期刊>BMJ Open >Evidence of Chinese herbal medicine Duhuo Jisheng decoction for knee osteoarthritis: a systematic review of randomised clinical trials
【24h】

Evidence of Chinese herbal medicine Duhuo Jisheng decoction for knee osteoarthritis: a systematic review of randomised clinical trials

机译:中药独活积生汤治疗膝骨性关节炎的证据:随机临床试验的系统评价

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objectives Duhuo Jisheng decoction (DJD) is considered beneficial for controlling knee osteoarthritis (KOA)-related symptoms in some Asian countries. This review compiles the evidence from randomised clinical trials and quantifies the effects of DJD on KOA. Designs 7 online databases were investigated up to 12 October 2015. Randomised clinical trials investigating treatment of KOA for which DJD was used either as a monotherapy or in combination with conventional therapy compared to no intervention, placebo or conventional therapy, were included. The outcomes included the evaluation of functional activities, pain and adverse effect. The risk of bias was evaluated using the Cochrane Collaboration tool. The estimated mean difference (MD) and SMD was within a 95% CI with respect to interstudy heterogeneity. Results 12 studies with 982 participants were identified. The quality presented a high risk of bias. Meta-analysis found that DJD combined with glucosamine (MD 4.20 (1.72 to 6.69); p0.001) or DJD plus meloxicam and glucosamine (MD 3.48 (1.59 to 5.37); p0.001) had a more significant effect in improving Western Ontario and McMaster Universities Arthritis Index (total WOMAC scores). Also, meta-analysis presented more remarkable pain improvement when DJD plus sodium hyaluronate injection (MD 0.89 (0.26 to 1.53); p=0.006) was used. These studies demonstrated that active treatment of DJD in combination should be practiced for at least 4?weeks. Information on the safety of DJD or comprehensive therapies was insufficient in few studies. Conclusions DJD combined with Western medicine or sodium hyaluronate injection appears to have benefits for KOA. However, the effectiveness and safety of DJD is uncertain because of the limited number of trials and low methodological quality. Therefore, practitioners should be cautious when applying DJD in daily practice. Future clinical trials should be well designed; more research is needed.
机译:目的在某些亚洲国家,独活吉生汤(DJD)被认为有助于控制膝骨关节炎(KOA)相关症状。这篇综述收集了来自随机临床试验的证据,并量化了DJD对KOA的影响。截至2015年10月12日,对Designs 7的在线数据库进行了调查。该研究包括随机临床试验,该研究调查了DAO用作单一疗法或与常规疗法相结合而不是干预,安慰剂或常规疗法的KOA的治疗方法。结果包括功能活动,疼痛和不良反应的评估。使用Cochrane协作工具评估了偏见的风险。就研究间异质性而言,估计的平均差异(MD)和SMD在95%CI之内。结果确定了982名参与者的12项研究。质量存在偏见的高风险。荟萃分析发现,DJD联合葡糖胺(MD 4.20(1.72至6.69); p <0.001)或DJD加美洛昔康和葡糖胺(MD 3.48(1.59至5.37); p <0.001)对改善安大略西部地区具有更显着的作用。和麦克马斯特大学关节炎指数(WOMAC总评分)。而且,当使用DJD加透明质酸钠注射液(MD 0.89(0.26至1.53); p = 0.006)时,荟萃分析显示出更明显的疼痛改善。这些研究表明,联合治疗DJD至少应进行4周。在少数研究中,关于DJD或综合疗法安全性的信息不足。结论DJD联合西药或透明质酸钠注射液似乎对KOA有好处。然而,由于试验数量有限且方法学质量低下,DJD的有效性和安全性尚不确定。因此,从业人员在日常练习中使用DJD时应谨慎。未来的临床试验应精心设计;需要更多的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号